Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.0B | 24.5B | 17.4B | 19.7B |
Cost of revenue | 9.2B | 17.4B | 12.2B | 13.4B |
Gross profit | 3.9B | 7.1B | 5.2B | 6.3B |
Operating expense | ||||
Research & development | 169.1M | 268.3M | — | — |
Selling general and admin | 1.4B | 2.0B | 3.6B | 3.5B |
Other operating expenses | 309.2M | -3.1B | — | — |
Operating income | 525.1M | 3.6B | 1.6B | 2.8B |
Non operating interest income | ||||
Income | 304.5M | 322.4M | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 2.1B | 2.2B | 3.3B |
Tax provision | 554.3M | 1.2B | 580.4M | 971.4M |
Net income | 584.0M | 865.0M | 1.7B | 2.4B |
Basic EPS | 2 | — | 9 | 6 |
Diluted EPS | 2 | — | 9 | 6 |
Basic average shares | — | — | 184.6M | 396.3M |
Diluted average shares | — | — | 184.6M | 396.3M |
EBITDA | 1.5B | 7.9B | 1.6B | 4.0B |
Net income from continuing op. | 1.2B | 2.6B | 2.2B | 3.4B |
Minority interests | 10.0M | 7.1M | 9.9M | 5.4M |
Preferred stock dividends | — | — | — | — |